Illumina, Inc. (ILMN)
USD 134.03
(-6.35%)
USD 134.03
(-6.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.26 Billion USD | -34.98% |
| 2022 | 3.47 Billion USD | 40.91% |
| 2021 | 2.46 Billion USD | 33.1% |
| 2020 | 1.85 Billion USD | 1.03% |
| 2019 | 1.83 Billion USD | -8.06% |
| 2018 | 1.99 Billion USD | 49.48% |
| 2017 | 1.33 Billion USD | 5.05% |
| 2016 | 1.27 Billion USD | 16.62% |
| 2015 | 1.09 Billion USD | -15.53% |
| 2014 | 1.29 Billion USD | 48.64% |
| 2013 | 868.59 Million USD | 3.11% |
| 2012 | 842.37 Million USD | 4.34% |
| 2011 | 807.36 Million USD | 159.1% |
| 2010 | 311.6 Million USD | 7.38% |
| 2009 | 290.2 Million USD | -27.45% |
| 2008 | 399.99 Million USD | -0.0% |
| 2007 | 400.01 Million USD | 634846.03% |
| 2006 | 63 Thousand USD | -63.37% |
| 2005 | 172 Thousand USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 25.61 Million USD | -2.58% |
| 2002 | 26.29 Million USD | 2864.71% |
| 2001 | 887 Thousand USD | -22.7% |
| 2000 | 1.14 Million USD | 76399.6% |
| 1999 | 1500.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.92 Billion USD | 28.34% |
| 2024 Q1 | 2.27 Billion USD | 0.62% |
| 2024 Q3 | 2.6 Billion USD | -8.46% |
| 2023 Q1 | 2.98 Billion USD | -14.26% |
| 2023 FY | 2.26 Billion USD | -34.98% |
| 2023 Q2 | 2.96 Billion USD | -0.64% |
| 2023 Q3 | 2.18 Billion USD | -26.21% |
| 2023 Q4 | 2.26 Billion USD | 3.43% |
| 2022 Q1 | 2.61 Billion USD | 5.91% |
| 2022 Q4 | 3.47 Billion USD | 39.78% |
| 2022 Q3 | 2.48 Billion USD | -3.9% |
| 2022 FY | 3.47 Billion USD | 40.91% |
| 2022 Q2 | 2.59 Billion USD | -0.96% |
| 2021 Q2 | 2.38 Billion USD | -15.62% |
| 2021 Q4 | 2.46 Billion USD | -0.08% |
| 2021 Q1 | 2.82 Billion USD | 52.24% |
| 2021 FY | 2.46 Billion USD | 33.1% |
| 2021 Q3 | 2.47 Billion USD | 3.69% |
| 2020 Q3 | 1.85 Billion USD | 0.43% |
| 2020 Q1 | 1.84 Billion USD | 0.6% |
| 2020 Q2 | 1.84 Billion USD | -0.22% |
| 2020 Q4 | 1.85 Billion USD | 0.22% |
| 2020 FY | 1.85 Billion USD | 1.03% |
| 2019 FY | 1.83 Billion USD | -8.06% |
| 2019 Q4 | 1.83 Billion USD | 0.77% |
| 2019 Q1 | 2.46 Billion USD | 23.23% |
| 2019 Q2 | 1.81 Billion USD | -26.13% |
| 2019 Q3 | 1.82 Billion USD | 0.22% |
| 2018 Q3 | 1.98 Billion USD | 45.29% |
| 2018 Q1 | 1.35 Billion USD | 1.12% |
| 2018 Q2 | 1.36 Billion USD | 1.33% |
| 2018 FY | 1.99 Billion USD | 49.48% |
| 2018 Q4 | 1.99 Billion USD | 0.4% |
| 2017 FY | 1.33 Billion USD | 5.05% |
| 2017 Q4 | 1.33 Billion USD | 2.3% |
| 2017 Q3 | 1.3 Billion USD | 0.62% |
| 2017 Q2 | 1.29 Billion USD | 4.01% |
| 2017 Q1 | 1.24 Billion USD | -1.87% |
| 2016 FY | 1.27 Billion USD | 16.62% |
| 2016 Q1 | 1.02 Billion USD | -6.23% |
| 2016 Q3 | 1.22 Billion USD | 18.26% |
| 2016 Q2 | 1.03 Billion USD | 0.9% |
| 2016 Q4 | 1.27 Billion USD | 4.22% |
| 2015 Q2 | 1.3 Billion USD | 0.16% |
| 2015 FY | 1.09 Billion USD | -15.53% |
| 2015 Q3 | 1.11 Billion USD | -14.82% |
| 2015 Q4 | 1.09 Billion USD | -1.76% |
| 2015 Q1 | 1.3 Billion USD | 0.79% |
| 2014 Q4 | 1.29 Billion USD | 0.79% |
| 2014 Q2 | 1.27 Billion USD | 49.87% |
| 2014 Q3 | 1.28 Billion USD | 0.79% |
| 2014 FY | 1.29 Billion USD | 48.64% |
| 2014 Q1 | 848.01 Million USD | -2.37% |
| 2013 FY | 868.59 Million USD | 3.11% |
| 2013 Q3 | 859.5 Million USD | 0.89% |
| 2013 Q2 | 851.9 Million USD | -1.03% |
| 2013 Q4 | 868.59 Million USD | 1.06% |
| 2013 Q1 | 860.74 Million USD | 2.18% |
| 2012 Q4 | 842.37 Million USD | 1.07% |
| 2012 FY | 842.37 Million USD | 4.34% |
| 2012 Q3 | 833.46 Million USD | 1.07% |
| 2012 Q1 | 815.96 Million USD | 1.07% |
| 2012 Q2 | 824.66 Million USD | 1.07% |
| 2011 Q3 | 798.87 Million USD | 0.12% |
| 2011 Q4 | 807.36 Million USD | 1.06% |
| 2011 FY | 807.36 Million USD | 159.1% |
| 2011 Q2 | 797.92 Million USD | 4.52% |
| 2011 Q1 | 763.4 Million USD | 144.99% |
| 2010 Q1 | 295.4 Million USD | 1.79% |
| 2010 Q4 | 311.6 Million USD | 1.8% |
| 2010 FY | 311.6 Million USD | 7.38% |
| 2010 Q3 | 306.1 Million USD | 1.8% |
| 2010 Q2 | 300.7 Million USD | 1.79% |
| 2009 Q1 | 274.79 Million USD | -31.3% |
| 2009 Q2 | 279.7 Million USD | 1.79% |
| 2009 Q3 | 284.7 Million USD | 1.79% |
| 2009 Q4 | 290.2 Million USD | 1.93% |
| 2009 FY | 290.2 Million USD | -27.45% |
| 2008 Q2 | 414.88 Million USD | 3.72% |
| 2008 Q1 | 400 Million USD | -0.0% |
| 2008 FY | 399.99 Million USD | -0.0% |
| 2008 Q4 | 399.99 Million USD | -0.15% |
| 2008 Q3 | 400.58 Million USD | -3.45% |
| 2007 Q4 | 400.01 Million USD | -0.0% |
| 2007 Q3 | 400.02 Million USD | -0.0% |
| 2007 Q2 | 400.04 Million USD | -0.01% |
| 2007 Q1 | 400.07 Million USD | 634936.51% |
| 2007 FY | 400.01 Million USD | 634846.03% |
| 2006 FY | 63 Thousand USD | -63.37% |
| 2006 Q4 | 63 Thousand USD | -32.98% |
| 2006 Q3 | 94 Thousand USD | -17.54% |
| 2006 Q2 | 114 Thousand USD | -20.28% |
| 2006 Q1 | 143 Thousand USD | -16.86% |
| 2005 FY | 172 Thousand USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | 172 Thousand USD | 0.0% |
| 2004 Q1 | 25.43 Million USD | -0.71% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q2 | 25.18 Million USD | -1.0% |
| 2003 Q4 | 25.61 Million USD | -0.66% |
| 2003 FY | 25.61 Million USD | -2.58% |
| 2003 Q1 | 25.96 Million USD | -1.26% |
| 2003 Q2 | 25.95 Million USD | -0.03% |
| 2003 Q3 | 25.78 Million USD | -0.65% |
| 2002 FY | 26.29 Million USD | 2864.71% |
| 2002 Q1 | 26.24 Million USD | 2858.74% |
| 2002 Q2 | 26.17 Million USD | -0.26% |
| 2002 Q4 | 26.29 Million USD | 0.71% |
| 2002 Q3 | 26.11 Million USD | -0.24% |
| 2001 Q1 | 1.08 Million USD | -5.41% |
| 2001 Q3 | 955.01 Thousand USD | -6.49% |
| 2001 FY | 887 Thousand USD | -22.7% |
| 2001 Q4 | 887 Thousand USD | -7.12% |
| 2001 Q2 | 1.02 Million USD | -5.91% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q4 | 1.14 Million USD | -4.98% |
| 2000 FY | 1.14 Million USD | 76399.6% |
| 2000 Q3 | 1.2 Million USD | -4.6% |
| 2000 Q2 | 1.26 Million USD | 0.0% |
| 1999 FY | 1500.00 USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | -2472.004% |
| Prenetics Global Limited | 2.36 Million USD | -95367.69% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -62576.642% |
| CareDx, Inc | 34.22 Million USD | -6509.976% |
| Exact Sciences Corporation | 2.55 Billion USD | 11.458% |
| Exagen Inc. | 23.72 Million USD | -9435.854% |
| Inotiv, Inc. | 417.64 Million USD | -441.613% |
| Guardant Health, Inc. | 1.35 Billion USD | -67.09% |
| Biodesix, Inc. | 60.69 Million USD | -3627.077% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1695615.731% |
| Precipio, Inc. | 1.11 Million USD | -202588.172% |
| iSpecimen Inc. | 196.24 Thousand USD | -1152546.705% |
| Natera, Inc. | 441.99 Million USD | -411.773% |
| Aspira Women's Health Inc. | 2.26 Million USD | -99723.477% |
| Standard BioTools Inc. | 98.21 Million USD | -2203.228% |
| 23andMe Holding Co. | 76.51 Million USD | -2856.283% |
| Castle Biosciences, Inc. | 15.31 Million USD | -14674.657% |
| Personalis, Inc. | 48.96 Million USD | -4519.909% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -530885.915% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -182649.483% |
| OpGen, Inc. | 13.04 Million USD | -17241.697% |
| T2 Biosystems, Inc. | 49.49 Million USD | -4469.882% |
| Myriad Genetics, Inc. | 145 Million USD | -1460.0% |
| ICON Public Limited Company | 3.93 Billion USD | 42.564% |
| NeoGenomics, Inc. | 611.67 Million USD | -269.802% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -62576.642% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -138.638% |
| RadNet, Inc. | 1.49 Billion USD | -51.698% |
| MDxHealth SA | 41.26 Million USD | -5381.643% |
| Psychemedics Corporation | 2.29 Million USD | -98333.42% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | -2304.618% |
| DarioHealth Corp. | 29.54 Million USD | -7557.154% |
| Fulgent Genetics, Inc. | 14.9 Million USD | -15074.079% |
| Sera Prognostics, Inc. | 1.85 Million USD | -121643.811% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -573425.049% |
| OPKO Health, Inc. | 326.56 Million USD | -592.667% |
| Medpace Holdings, Inc. | 142.12 Million USD | -1491.59% |
| Neogen Corporation | 906.23 Million USD | -149.603% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -259470.366% |
| Prenetics Global Limited | 2.36 Million USD | -95367.69% |
| Mainz Biomed B.V. | 7.42 Million USD | -30381.971% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -143187.984% |
| Trinity Biotech plc | 67.42 Million USD | -3254.739% |
| Neuronetics, Inc. | 62.47 Million USD | -3520.706% |
| Sotera Health Company | 2.32 Billion USD | 2.796% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -143187.984% |